|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.39 INR | +4.82% |
|
+4.82% | -2.85% |
| 05-24 | Raymed Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
| 05-24 | Raymed Labs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
Raymed Labs Limited reported earnings results for the fourth quarter ended March 31, 2023. For the fourth quarter, the company reported revenue was INR 0.206 million. Net loss was INR 0.789 million compared to INR 0.439 million a year ago.
Basic loss per share from continuing operations was INR 0.1847 compared to INR 0.1028 a year ago. Diluted loss per share from continuing operations was INR 0.1847 compared to INR 0.1028 a year ago.
RAYMED LABS LIMITED